Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 110

1.

The Prevalence of Hydroxychloroquine Retinopathy and Toxic Dosing, and the Role of the Ophthalmologist in Reducing Both.

Browning DJ.

Am J Ophthalmol. 2016 Aug 17. pii: S0002-9394(16)30347-6. doi: 10.1016/j.ajo.2016.07.007. [Epub ahead of print] No abstract available.

PMID:
27544041
2.

Vitrectomy for center-involved diabetic macular edema.

Browning DJ, Lee C, Stewart MW, Landers MB 3rd.

Clin Ophthalmol. 2016 Apr 26;10:735-42. doi: 10.2147/OPTH.S104906. eCollection 2016.

3.

The Prevalence of Hydroxychloroquine Retinopathy and Toxic Dosing, and the Role of the Ophthalmologist in Reducing Both.

Browning DJ.

Am J Ophthalmol. 2016 Jun;166:ix-xi. doi: 10.1016/j.ajo.2016.03.044. Epub 2016 Apr 28. No abstract available.

PMID:
27133016
4.

Correspondence.

Stewart MW, Landers MB 3rd, Browning DJ, Murata T, Ohji M, Nawrocki J, Chhablani JK.

Retina. 2016 Mar;36(3):e22-3. doi: 10.1097/IAE.0000000000000957. No abstract available.

PMID:
26841212
5.

The Association of Statin Use with Cataract Progression and Cataract Surgery: The AREDS2 Report Number 8.

AREDS2 Research Group, Al-Holou SN, Tucker WR, Agrón E, Clemons TE, Sperduto RD, Ferris FL 3rd, Chew EY.

Ophthalmology. 2016 Apr;123(4):916-7. doi: 10.1016/j.ophtha.2015.10.040. Epub 2015 Dec 11. No abstract available.

PMID:
26686966
6.

Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema.

Wells JA, Glassman AR, Jampol LM, Aiello LP, Antoszyk AN, Baker CW, Bressler NM, Browning DJ, Connor CG, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW; Diabetic Retinopathy Clinical Research Network.

JAMA Ophthalmol. 2016 Feb;134(2):127-34. doi: 10.1001/jamaophthalmol.2015.4599.

PMID:
26605836
7.

Vitrectomy for Proliferative Diabetic Retinopathy: Does Anyone Know the Complication Rate?

Browning DJ.

JAMA Ophthalmol. 2016 Jan;134(1):86-7. doi: 10.1001/jamaophthalmol.2015.4597. No abstract available.

PMID:
26583811
8.

Re: Saksens et al.: Dominant cystoid macular dystrophy (Ophthalmology 2015;122:180-91).

Pautler SE, Browning DJ.

Ophthalmology. 2015 Oct;122(10):e59-60. doi: 10.1016/j.ophtha.2015.02.042. No abstract available.

PMID:
26398057
9.

Scotoma analysis of 10-2 visual field testing with a red target in screening for hydroxychloroquine retinopathy.

Browning DJ, Lee C.

Clin Ophthalmol. 2015 Aug 20;9:1499-509. doi: 10.2147/OPTH.S87850. eCollection 2015.

10.

Re: Impact of Macula-off Retinal Detachment on Visual Outcome, A Systematic Review and Meta-Analysis of Literature.

Browning DJ, Pautler SE, Wong KL, Telander DG, Stewart MW.

Retina. 2015 Jul;35(7):e44. doi: 10.1097/IAE.0000000000000673. No abstract available.

PMID:
26098277
11.

Scotoma analysis of 10-2 visual field testing with a white target in screening for hydroxychloroquine retinopathy.

Browning DJ, Lee C.

Clin Ophthalmol. 2015 May 27;9:943-52. doi: 10.2147/OPTH.S82398. eCollection 2015.

12.

Re: Pachychoroid neovasculopathy.

Pautler SE, Browning DJ.

Retina. 2015 Jul;35(7):e39-40. doi: 10.1097/IAE.0000000000000661. No abstract available.

PMID:
26057392
13.

Near-infrared reflectance bull's eye maculopathy as an early indication of hydroxychloroquine toxicity.

Wong KL, Pautler SE, Browning DJ.

Clin Ophthalmol. 2015 Mar 19;9:521-5. doi: 10.2147/OPTH.S76963. eCollection 2015.

14.

Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.

Diabetic Retinopathy Clinical Research Network, Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW.

N Engl J Med. 2015 Mar 26;372(13):1193-203. doi: 10.1056/NEJMoa1414264. Epub 2015 Feb 18.

15.

Isolated posterior uveal effusion: expanding the spectrum of the uveal effusion syndrome.

Pautler SE, Browning DJ.

Clin Ophthalmol. 2014 Dec 30;9:43-9. doi: 10.2147/OPTH.S75448. eCollection 2015.

16.

Test-retest variability of multifocal electroretinography in normal volunteers and short-term variability in hydroxychloroquine users.

Browning DJ, Lee C.

Clin Ophthalmol. 2014 Aug 7;8:1467-73. doi: 10.2147/OPTH.S66528. eCollection 2014.

18.

The impact of different algorithms for ideal body weight on screening for hydroxychloroquine retinopathy in women.

Browning DJ, Lee C, Rotberg D.

Clin Ophthalmol. 2014 Jul 24;8:1401-7. doi: 10.2147/OPTH.S66531. eCollection 2014.

19.

Reply: To PMID 23218706.

Browning DJ.

Am J Ophthalmol. 2013 Aug;156(2):410-1. doi: 10.1016/j.ajo.2013.04.011. No abstract available.

PMID:
23870364
20.

Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial.

Bressler SB, Qin H, Melia M, Bressler NM, Beck RW, Chan CK, Grover S, Miller DG; Diabetic Retinopathy Clinical Research Network.

JAMA Ophthalmol. 2013 Aug;131(8):1033-40. doi: 10.1001/jamaophthalmol.2013.4154.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk